Home/Pipeline/B3 GEL™ System

B3 GEL™ System

Prevention of post-surgical adhesions and tethering in tendon and ligament repair

Pre-clinicalActive

Key Facts

Indication
Prevention of post-surgical adhesions and tethering in tendon and ligament repair
Phase
Pre-clinical
Status
Active
Company

About TYBR Health

TYBR Health is a private, pre-revenue medical device company focused on solving the pervasive problem of post-surgical adhesions that limit patient mobility despite technically successful surgeries. Its lead product, the B3 GEL™ System, is a flowable, blue-tinted hydrogel barrier that physically separates healing tissues during the critical recovery window to prevent restrictive scar formation. Founded in 2019 and based in Austin, Texas, the company has developed its technology through NIH-funded and university-collaborative research, generating preclinical data demonstrating improved range of motion and reduced adhesions without impairing tendon gliding. TYBR is now positioned to bring this integrated surgical solution to the substantial market of orthopedic and hand surgery procedures.

View full company profile